Schoder H, Fury M, Lee N, Kraus D (2009) PET monitoring of therapy response in head and neck
squamous cell carcinoma. J Nucl Med 50(Suppl 1):74S–88S. doi:10.2967/jnumed.108.057208
Smits M, Vernooij MW, Wielopolski PA, Vincent AJ, Houston GC, van der Lugt A (2007)
Incorporating functional MR imaging into diffusion tensor tractography in the preoperative
assessment of the corticospinal tract in patients with brain tumors. AJNR Am J Neuroradiol 28
(7):1354–1361. doi:10.3174/ajnr.A0538
Srinivasan A, Mohan S, Mukherji SK (2012) Biologic imaging of head and neck cancer: the
present and the future. AJNR Am J Neuroradiol 33(4):586–594. doi:10.3174/ajnr.A2535
Terra SG, Johnson JA (2002) Pharmacogenetics, pharmacogenomics, and cardiovascular thera-
peutics: the way forward. Am J Cardiovasc Drugs 2(5):287–296
Thrall JH (2004) Personalized medicine. Radiology 231(3):613–616. doi:10.1148/radiol.
2313040323
Van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, van Iersel CA,
van den Bergh KA, van‘t Westeinde S, van der Aalst C, Thunnissen E, Xu DM, Wang Y,
Zhao Y, Gietema HA, de Hoop BJ, Groen HJ, de Bock GH, van Ooijen P, Weenink C,
Verschakelen J, Lammers JW, Timens W, Willebrand D, Vink A, Mali W, de Koning HJ
(2009) Management of lung nodules detected by volume CT scanning. N Engl J Med 361
(23):2221–2229. doi:10.1056/NEJMoa0906085
Vandecaveye V, De Keyzer F, Nuyts S, Deraedt K, Dirix P, Hamaekers P, Vander Poorten V,
Delaere P, Hermans R (2007) Detection of head and neck squamous cell carcinoma with
diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histo-
pathologic findings. Int J Radiat Oncol Biol Phys 67(4):960–971. doi:10.1016/j.ijrobp.2006.09.
020
Vanden Bempt I, Drijkoningen M, De Wolf-Peeters C (2007) The complexity of genotypic
alterations underlying HER2-positive breast cancer: an explanation for its clinical heteroge-
neity. Curr Opin Oncol 19(6):552–557. doi:10.1097/CCO.0b013e3282f0ad8e
Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ,
Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ, Press M (2002) Efficacy and
safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing meta-
static breast cancer. J Clin Oncol 20(3):719–726
Welch HG, Black WC (2010) Overdiagnosis in cancer. J Natl Cancer Inst 102(9):605–613. doi:10.
1093/jnci/djq099
230 D. Miletic ́et al.